Expert's Opinion
-
Clinical Trials | Information Technology
Adding Remote Site Access to Sponsor Bids: What to Know as CRO
Traditional monitoring has changed, CROs should build a portfolio of remote access solutions and have them ready.Ryan Jones, CEO, Florence Healthcare 10.13.20
-
Drug Development
New York City is Not Dead, Our Life Sciences Sector is Thriving
Amid the COVID-19 pandemic, life sciences is booming in NYC!Sara Jane Demy, CEO & Founder, Demy-Colton 10.01.20
-
Facilities
The Changing Approach to Design: Five Ways to Achieve Warp Speed
Revisiting facility design and construction based on today’s biopharmaceutical industry needs.Jarrod Wrampe, Project Manager, CRB 09.30.20
-
Puerto Rico is Primed to Take Over the Biosciences World Stage – Here's Why
Is Puerto Rico the solution to reshoring pharmaceutical and medical equipment manufacturing stateside?Michael P. Gay, CEcD, Chief Business Development Officer, Invest Puerto Rico 09.24.20
-
Clinical Trials | Drug Development
How to Balance Internal and External Staff Within Outsourcing Models
Strategies to consider in flexed staffing models.John Barry, SVP, Consulting Practice and Chief Strategy Officer, PRA Health Sciences, SSD 09.22.20
-
Biologics, Proteins, Vaccines | Drug Development
The Importance of Global Collaboration in the Fight Against COVID-19
Industry continues to join forces to find new treatments for COVID-19.Dohyun Cho, Chief Operating Officer, Enzychem Lifesciences 09.08.20
-
Clinical Trials | Drug Development
FDA Response to COVID-19
A Discussion on Protocol Amendments and Clinical Study Reports in Affected Ongoing Trials.Jack Modell, M.D., Vice President and Senior Medical Officer, Rho 09.03.20
-
Clinical Trials | Drug Development
Beyond 2020: The Future of CROs
How will remote site access impact the CRO business?Ryan Jones, CEO, Florence Healthcare 08.21.20
-
Biologics, Proteins, Vaccines | Clinical Trials | Drug Development
Global Biotech: Leading Health Care Innovation and How CROs Are Adapting to Meet Their Needs
New models from CROs are enabling further biotech expansionDavide Garrisi, Biotech Portfolio Lead, PPD Biotech 08.20.20
-
Clinical Trials | Drug Development
Pharma’s Imperative: Rethinking the FSP Outsourcing Paradigm
Evaluating outsourcing strategies amid a complex trial landscape to further enhance clinical operations.Michael D. Jones , Vice President of Clinical FSP Client Engagement, IQVIA 08.17.20
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development
Tackling Analytical Challenges in Gene Therapy
Key considerations on how to navigate the field as a gene therapy developer.Khanh Ngo Courtney, Ph.D., Biologics Project Director, Avomeen 07.17.20
-
Supply Chain
The COVID-19 Pandemic Sheds Light on the Over-Reliance on Offshore Drug Manufacturers
Four ideas to bring drug substance and drug product manufacturing back to the U.S.Ed Price, President, Seqens North America 06.29.20
-
APIs
Are the Challenges of Chinese API Manufacturing Sparking a Shift Back to the US?
Five challenges that face U.S. and Chinese API manufacturing relations.Ed Price, President, Seqens North America 06.19.20
-
Drug Development | GMPs/GCPs | Information Technology | QA/QC
Solving Compliance Challenges and Beyond with Natural Language Processing
Understanding new data sources and elevating compliance to drive innovation.Updesh Dosanjh, Practice Lead, IQVIA Vigilance Platform, IQVIA, Jane Reed, Head of Life Science Strategy, Linguamatics, an IQVIA company 06.16.20
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Logistics | Supply Chain
New Supply Chain Considerations in Response to COVID-19
Cell & gene therapy companies have faced unique challenges due to the nature of their therapies, this is especially true for autologous cell therapies.Mark Stielow, Senior Director of Cell Manufacturing & Technical Operations, Adaptimmune 06.10.20
-
Capsules | Cold Chain Management | Injectables | Serialization | Solid Dosage/Semi-solids | Supply Chain
Pharmaceutical Packaging Trends
Opportunities across next-gen products, transforming how chronic diseases are treated, and favorable government regulations are driving today's market.Thomas N. Podesta, Global Vice President, Sales, West Contract Manufacturing 06.02.20
-
Facilities | Information Technology
Prepare Your Facility for a Pandemic – How Data Can Help
Data is being used to monitor and reduce the impact of the virus, and to allocate resources and anticipate needs.David Keith, Director of Strategic Facility Planning, CRB 05.29.20
-
Biologics, Proteins, Vaccines | Clinical Trials | Drug Development | Logistics
The Importance of CAR-T Cell Therapy in Clinical Trials
The Industry’s Evolving, Maturing FocusPanteli Theocharous, Global Vice President, Cell and Gene Therapy Strategy Lead, PPD 05.26.20
-
cGMP Manufacture | Clinical Trials | Drug Development | Information Technology | R&D
COVID-19’s Long-Term Impact on Drug Development: The New Pragmatism
The rise of new tools and approaches, an increase in regulatory responsibility, and the need for speed.Paul Bridges SVP Worldwide Head Regulatory & Access, Parexel and Sheela Hegde, Partner and Managing Director, Health Advances 05.18.20
-
Supply Chain
Maximizing Potential
Creatively navigating the clinical supply chain challenges during COVID-19Sharon Courtney, Logistics Services Manager, Almac 05.04.20
